A clickable multi-factor authentication link, valid for 20 minutes, is sent to users via email to verify identify upon log in.

21 November 2018
WHO Headquarters
Europe/Zurich timezone
The Sabin IPV advisory panel convenes once a year to discuss the Sabin IPV technology transfer project. The Sabin IPV technology transfer project, a collaboration between WHO and Intravacc, aims to develop safer processes for the production of inactivated poliovirus vaccine (IPV) and facilitate the manufacture of Sabin IPV in developing countries, in line with WHA resolution 6.1.
Starts
Ends
Europe/Zurich
In-Person
WHO Headquarters, Geneva, Switzerland
M605
Mbuilding 20, avenue Appia Geneva
Go to map